MoneyWorks4Me

Dr. Reddys Laboratories informs about company updates

17 Feb 2020 Evaluate

Further to the intimation dated August 20, 2019 with regard to the audit of its Formulations Manufacturing Plant ('Vizag SEZ Plant 1 - FTO 7') at Duvvada, Visakhapatnam, Dr. Reddys Laboratories has informed that the company has been notified by the US FDA, that the inspection classification of the above-referred facility is determined as Voluntary Action Initiated (VAI).

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..